MYADML2 Inhibitors
MYADML2 inhibitors represent a specialized chemical class designed to selectively target and modulate the function of the MYADML2 protein. MYADML2, also known as Myeloid-associated differentiation marker-like 2, is a protein whose specific molecular functions and cellular roles are subjects of ongoing research. The inhibitors developed for MYADML2 are intricately designed to interact with the unique structural features of this protein, aiming to disrupt its normal interactions within the cellular environment and potentially influence various cellular regulatory pathways.
The molecular architecture of MYADML2 inhibitors is precisely tailored to engage specific binding sites on the protein, inducing changes in its conformation and dynamics. MYADML2 may play a role in cellular differentiation or other processes associated with myeloid cells, given its nomenclature. In laboratory research, these inhibitors serve as crucial tools, enabling scientists to probe the nuanced functions of MYADML2 in various cellular contexts. By manipulating the function of MYADML2, researchers aim to unravel the complex mechanisms underlying its cellular roles and contributions to cellular homeostasis. The study of MYADML2 inhibitors stands at the forefront of advancing our understanding of this enigmatic protein and its potential implications in cellular biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Inhibits ribonucleotide reductase, decreasing the pool of deoxyribonucleotides available for DNA synthesis, potentially affecting cell cycle proteins. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $57.00 $200.00 | 15 | |
This nucleotide analog interferes with DNA synthesis and can disrupt the cell cycle, potentially downregulating associated proteins. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $82.00 $300.00 $1082.00 | 30 | |
A specific inhibitor of DNA polymerase α and δ, which can prevent DNA replication and thus may inhibit cell cycle-related protein expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Targets topoisomerase II, leading to DNA damage and cell cycle arrest, which may impact the expression of cell cycle proteins. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Crosslinks DNA, leading to cell cycle arrest and potentially affecting the expression of proteins involved in DNA synthesis and cell cycle. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
A nucleoside analog that causes DNA chain termination during replication, potentially disrupting the cell cycle and associated proteins. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
Inhibits cyclin-dependent kinases CDK4 and CDK6, which are critical for cell cycle progression, possibly affecting related proteins. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Inhibits multiple cyclin-dependent kinases (CDKs), which could lead to cell cycle arrest and impact associated protein expression. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $115.00 $337.00 | 3 | |
Induces apoptosis and may disrupt cell cycle progression, potentially downregulating cell cycle-associated proteins. | ||||||
Thiostrepton | 1393-48-2 | sc-203412 sc-203412A | 1 g 5 g | $115.00 $415.00 | 10 | |
Interferes with protein synthesis at the ribosomal level, which could indirectly affect the levels of numerous cell cycle-related proteins. | ||||||